ITM Appoints Dr. Mark Harfensteller as Member of its Executive Board
16 janv. 2024 05h00 HE
|
ITM Isotope Technologies Munich SE
Garching / Munich, Germany, January 16, 2024 – ITM Isotope Technologies Munich SE (ITM), a leading radiopharmaceutical biotech company, today announced the appointment of Dr. Mark Harfensteller to its...